Article thumbnail

Ewing’s sarcoma as second malignancy following a short latency in unilateral retinoblastoma

By Naveen Tahasildar, Vijay Goni, Kishan Bhagwat, Sujit Kumar Tripathy and Bijnya Birajita Panda

Abstract

Second malignancies, mostly in the form of bone sarcomas, are known to occur in hereditary retinoblastomas, which usually present with bilateral disease. Only 2 cases of Ewing’s sarcoma have been reported in the literature following sporadic unilateral retinoblastoma. A 5-year-old boy presented to our hospital with Ewing’s sarcoma of the right humerus (proven by biopsy and immunohistochemistry) following successful treatment of retinoblastoma of the left eye with enucleation and chemotherapy 2 years previously. He was treated with 2 cycles of chemotherapy followed by radiation therapy. At 15 months follow-up, the tumor had reduced in size and the child had a good functional outcome. The cumulative risk of second malignancies in retinoblastoma survivors is 32%. Ninety-eight percent of second malignancies occur in patients with bilateral retinoblastoma. Germ line mutations have been considered in sporadic tumors occurring bilaterally and multifocal unilateral sporadic tumors. Bone and soft tissue sarcomas are the most common second malignancies. Radiation therapy increases the risk of developing a second malignancy in the irradiated field. Unilateral retinoblastomas, which comprise the majority of retinoblastomas, are not immune from the development of second malignancies. Close follow-up of all retinoblastomas—even in the early period—can improve the outcome by facilitating the early detection and aggressive treatment of second malignancies

Topics: Case Report
Publisher: Springer Milan
OAI identifier: oai:pubmedcentral.nih.gov:3163792
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1986). A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.
  2. (1993). Bone tumors other than osteosarcoma after retinoblastoma.
  3. (2008). Ewing’s sarcoma as second malignant neoplasm after retinoblastoma: a case report.
  4. (1983). Ewing’s tumor following bilateral retinoblastoma.
  5. (1987). For the Late Effects Study Group. Bone sarcomas linked to radiotherapy and chemotherapy in children.
  6. (1976). Genetics of retinoblastoma. In: Reese AB (ed) Tumors of the eye, 3rd edn. Harper and Row,
  7. (1993). Genetics of tumors of the head and neck. Arch Otolaryngol Head Neck Surg 119:737
  8. (1982). Incidence of second malignant neoplasms in children: results of an international study.
  9. (1988). Incidence of second neoplasms in patients with bilateral retinoblastoma.
  10. (1996). Osteosarcoma and Ewing’s sarcoma in a retinoblastoma patient. Clin Orthop Rel Res 323:284–287
  11. (2004). Outcome of second malignancies after retinoblastoma: a retrospective analysis of 25 patients treated at the Institut Curie.
  12. (1969). Radiation induced neoplasia following external beam therapy for children with retinoblastoma.
  13. (1978). Retinoblastoma: a prototypic hereditary neoplasm.
  14. (1995). Second malignant neoplasms in children with retinoblastoma: the St. Jude Children’s Research Hospital experience.
  15. (1984). Second nonocular tumors in retinoblastoma survivors: are they radiation induced?
  16. (1986). Second primary neoplasms in patients with retinoblastoma.
  17. (1990). Skeletal scintigraphy in patients with bilateral retinoblastoma.